Companies / Japan
US Gives Cautious Welcome To Japan's Regulatory Reforms
July 2006 | Industry NewsA review by the Office of the US Trade Representative (USTR), commenting on Japan's progress on reforms to industrial regulation, has given a guarded welcome to changes in drug sector policy. The report comes as part of the annual US submission under the US-Japan Regulatory Reform and Competition Policy Initiative, instituted in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
